The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

START and OneOncology launch 3 new early-phase trial sites, expanding access to new cancer research in community oncology ...

As shown in table 2, both OS and CBR values were in line or higher than those reported in the treatment arm of the ASCENT ...

An innovative new treatment for tackling some of the toughest stomach cancers has shown promise in a phase 2 clinical trial, ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

The trial, which was funded by a National Institute for Health and Care Research (NIHR) Health Technology Assessment grant, ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...